openPR Logo
Press release

Key Trends Shaping the Future Antipsychotic Drugs Market From 2025-2034: Advancements In Subcutaneous Antipsychotic Injections For Enhanced Patient Compliance And Efficacy

03-18-2025 04:31 AM CET | Health & Medicine

Press release from: The Business Research Company

Antipsychotic Drugs

Antipsychotic Drugs

What combination of drivers is leading to accelerated growth in the antipsychotic drugs market?
The antipsychotic drug market is anticipated to surge due to the rising prevalence of mental disorders. Mental disorders, also referred to as mental illnesses, affect an individual's thought process, behavior, mood, and overall mental health. These disorders can be influenced by factors such as stress, societal pressures, genetic factors, biochemical imbalance, neurodevelopmental problems, and physical health conditions. Antipsychotic medicines help manage these mental disorders by changing the neurotransmitters' activity, especially dopamine and serotonin, which in turn helps reduce psychotic symptoms, stabilize mood, and enhance cognitive and emotional functionality. As per a survey in November 2023 by the Substance Abuse and Mental Health Services Administration (SAMHSA), a US government public health agency, about 6%, equivalent to 15.4 million individuals aged 18 or older, reported coping with severe mental illness (SMI). Additionally, the Australian Institute of Health and Welfare predicted in September 2024 that the number of dementia patients in Australia will more than double from around 411,100 in 2023 to 849,300 by 2058 affecting roughly 315,500 men and 533,800 women. This rising prevalence of mental disorders is hence fueling the growth of the antipsychotic drug market.

Get Your Antipsychotic Drugs Market Report Here:
https://www.thebusinessresearchcompany.com/report/antipsychotic-drugs-global-market-report

What is the projected compound annual growth rate (CAGR) of the antipsychotic drugs market from 2025 to 2034, and what factors influence it?
Over recent years, the market size for antipsychotic drugs has seen a significant expansion. Rising from $19.5 billion in 2024, the market is expected to reach $21.45 billion in 2025, demonstrating a compound annual growth rate (CAGR) of 10.0%. This impressive growth throughout the historic period is due to several influential factors. These include an increasing occurrence of mental health disorders, the creation of second-generation antipsychotic drugs, a swelling elderly population, advancements in healthcare infrastructure, and substantial investment directed towards research and development.

The market for antipsychotic medications is anticipated to witness substantial growth in the upcoming years, increasing to a valuation of $31.04 billion by 2029, with a compound annual growth rate (CAGR) of 9.7%. Contributing factors to the growth during the projected period include a rise in schizophrenia and bipolar disorder cases, constructive government policies, and funding, escalating demand for personalized treatments, the goal to lessen adverse effects, and the expansion of mental health advocacy groups and support systems. Notable trends for this period encompass the incorporation of digital health instruments for tracking, the creation of new modes of action, a growing emphasis on combination therapies, the use of pharmacogenomics for customized treatments, and a focus on patient-oriented drug development.

Get Your Free Sample Now - Explore Exclusive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=18780&type=smp

How are the latest trends influencing the growth of the antipsychotic drugs market?
Top-tier organizations present in the antipsychotic drug market are centering their operations around developing advanced medical solutions such as atypical antipsychotic injections given subcutaneously. These alternative medical products offer better patient adherence and increased effectiveness compared to traditional orally administered medicines. Subcutaneous atypical antipsychotic injections are psychiatric medicines injected beneath the skin to manage mental disorders, maintain consistent blood concentrations, and boost symptom control. Case in point, in April 2023, Teva Pharmaceutical Industries Ltd., from Israel, and French-based MedinCell SA rolled out UZEDY, a U.S. Food and Drug Administration (FDA) approved product. This is an extended-release injectable iteration of risperidone purposed for long-lasting subcutaneous administration allowing flexible dosing duration of one or two months. UZEDY employs MedinCell's exclusive SteadyTeq technology, guaranteeing constant medication release, achieving therapeutic levels within 6-24 hours post-administration. In the clinical study, UZEDY exhibited up to 80% decrease in the probability of schizophrenia relapse when compared to the placebo. This product aims to counter the frequent adherence issues tied to oral antipsychotics, which are frequently responsible for relapses.

What are the major segments of the antipsychotic drugs market and their role in driving growth?
The antipsychotic drugs market covered in this report is segmented -

1) By Therapeutic Class: First Generation, Second Generation, Third Generation
2) By Disease: Schizophrenia, Bipolar Disorder, Unipolar Depression, Dementia, Other Diseases
3) By Distribution Channel: Hospital Pharmacies, Drug Stores, Online Pharmacies

Subsegments:
1) By First Generation: Typical Antipsychotics, Phenothiazines, Butyrophenones, Thioxanthenes, Dibenzoxazepines
2) By Second Generation: Atypical Antipsychotics, Clozapine, Olanzapine, Risperidone, Quetiapine, Aripiprazole, Paliperidone, Lurasidone
3) By Third Generation: Partial Dopamine Agonists, Aripiprazole, Brexpiprazole, Cariprazine

Unlock Exclusive Market Insights - Purchase Your Research Report Now!
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=18780

Which regions are key players in the growth of the antipsychotic drugs market?
North America was the largest region in the antipsychotic drugs market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the antipsychotic drugs market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Who are the key firms paving the way for growth in the antipsychotic drugs market?
Major companies operating in the antipsychotic drugs market are Pfizer Inc., Johnson & Johnson Services Inc., Merck And Co. Inc., AbbVie Inc., Bristol-Myers Squibb Company, AstraZeneca PLC, GlaxoSmithKline PLC, Takeda Pharmaceutical Company Limited, Eli Lilly And Company, Teva Pharmaceutical Industries Ltd., Sun Pharmaceutical Industries Ltd., Otsuka Pharmaceutical Co. Ltd., Aurobindo Pharma Ltd., Cipla Ltd., H. Lundbeck A/S, Dr. Reddy's Laboratories Ltd., Intas Pharmaceuticals Ltd., Apotex Inc., Lupin Limited, Glenmark Pharmaceuticals Ltd., Torrent Pharmaceuticals Ltd., Alkermes plc

Customize Your Report - Get Tailored Market Insights!
https://www.thebusinessresearchcompany.com/customise?id=18780&type=smp

What Is Covered In The Antipsychotic Drugs Global Market Report?

•Market Size Forecast: Examine the antipsychotic drugs market size across key regions, countries, product categories, and applications.
•Segmentation Insights: Identify and classify subsegments within the antipsychotic drugs market for a structured understanding.
•Key Players Overview: Analyze major players in the antipsychotic drugs market, including their market value, share, and competitive positioning.
•Growth Trends Exploration: Assess individual growth patterns and future opportunities in the antipsychotic drugs market.
•Segment Contributions: Evaluate how different segments drive overall growth in the antipsychotic drugs market.
•Growth Factors: Highlight key drivers and opportunities influencing the expansion of the antipsychotic drugs market.
•Industry Challenges: Identify potential risks and obstacles affecting the antipsychotic drugs market.
•Competitive Landscape: Review strategic developments in the antipsychotic drugs market, including expansions, agreements, and new product launches.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Key Trends Shaping the Future Antipsychotic Drugs Market From 2025-2034: Advancements In Subcutaneous Antipsychotic Injections For Enhanced Patient Compliance And Efficacy here

News-ID: 3920062 • Views:

More Releases from The Business Research Company

Global Print Label Market Analysis 2025-2030: Growth Drivers, Challenges, And Opportunities
Global Print Label Market Analysis 2025-2030: Growth Drivers, Challenges, And Op …
The Print Label Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories]. What Is the Projected Growth of the Print Label Market? The market size for print labels has experienced robust growth over the past few years. It is projected to expand from $47.04 billion in 2024
Strong Growth Ahead: Preparation of Coffee Extracts Market Size To Grow At Arecord 6.6% Cagr By 2029
Strong Growth Ahead: Preparation of Coffee Extracts Market Size To Grow At Areco …
The Preparation of Coffee Extracts Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories]. What Is the Projected Growth of the Preparation of Coffee Extracts Market? The market size for coffee extracts preparation has shown significant expansion recently. The market anticipates growth from $7.06 billion in 2024
Emerging Trends Influencing The Growth Of The Pork Market:Innovation In The Pork Market Cargill Introduces Omega-3 Pork In Collaboration With Ek Slaughterhouse
Emerging Trends Influencing The Growth Of The Pork Market:Innovation In The Pork …
The Pork Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories]. What Is the Projected Growth of the Pork Market? In recent times, the size of the pork market has been on a consistent upward trend. It is projected to rise from $154.53 billion in 2024 to
Global Polymer Foam Market Analysis 2025-2030: Growth Drivers, Challenges, And Opportunities
Global Polymer Foam Market Analysis 2025-2030: Growth Drivers, Challenges, And O …
The Polymer Foam Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories]. What Is the Projected Growth of the Polymer Foam Market? In recent years, the polymer foam market has experienced significant growth. The market, which was valued at $112.76 billion in 2024, is predicted to reach

All 5 Releases


More Releases for Pharma

Antiemetics Market Size 2022 Analysis by Top Key Players| Acacia Pharma Group Pl …
Antiemetics Market research added by the Absolute Markets Insights, offers a comprehensive analysis of growth trends prevailing in the global business domain. This report also provides definitive data concerning market, size, commercialization aspects and revenue forecast of the industry. In addition, the study explicitly highlights the competitive status of key players within the projection timeline while focusing on their portfolio and regional expansion endeavors. Access the PDF sample of the report@
Global Indomethacin Market Seeking Excellent Growth by 2028 | Ratiopharm, Merck, …
"IBI has published a report entitled Global Indomethacin Market Research Report which provides comprehensive data on emerging trends, market drivers, growth opportunities, and barriers that could change the dynamics of the industry market. It provides an in-depth analysis of market segments which includes the product, application, and competitor analysis. Click Here To Order A Sample Copy Of Indomethacin Global Market Report : https://www.infinitybusinessinsights.com/request_sample.php?id=380382 The Indomethacin Global Market Research Report provides close monitoring
Roxatidine Market 2020: Top Companies Analysis To Grow Healthcare Business by 20 …
Business Industry Reports Research has recently announced a report on Global Roxatidine Market based on the Category Industry. The Roxatidine Market report emphasizes various key aspects, which include growth drivers, restraints, opportunities and recent market trends for the forecast period 2020-2024. Global Roxatidine Market overview: Business Industry Reports Analyst covers the Major Players data, including: shipment, revenue, gross profit, interview record, business distribution etc., these data help the consumer know about the
Indometacin Market Top Key Manufacturers Aidarex, Ratiopharm, Merck, Xinhua Phar …
The Global Indometacin Market is a nonsteroidal anti-inflammatory drug commonly used as a prescription medication to reduce fever, pain, stiffness, and swelling from inflammation. The demand for nonsteroidal anti-inflammatory drug has been increasing owing to the emergence of anti-inflammatory biologics that are more targeted. However, such as side effects of anti-inflammatory drugs and patent expiry issues may hamper the market growth in the review period. For More Info, Get Sample Report
Hydroxycarbamide Market Study Report 2019| Taj Pharma, Beijing Jialin Pharma, Qi …
Los Angeles, United State, June 11, 2019, - The global Hydroxycarbamide market is expected to surge at a steady CAGR in the coming years, states the latest QY Research report. The publication offers an insightful take on the historical data of the market and the milestones it has achieved. The report also includes an assessment of current market trends and dynamics, which helps in mapping the trajectory of the global Hydroxycarbamide
TIGLUTIK Market 2019: Top Players are Sanofi, Mylan Pharma, Apotex, Glemark Gene …
TIGLUTIK Market 2019 Report analyses the industry status, size, share, trends, growth opportunity, competition landscape and forecast to 2025. This report also provides data on patterns, improvements, target business sectors, limits and advancements. Furthermore, this research report categorizes the market by companies, region, type and end-use industry. Get Sample Copy of this Report@ https://www.researchreportsworld.com/enquiry/request-sample/13709986 Global TIGLUTIK market 2019 research provides a basic overview of the industry including definitions, classifications, applications